Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Arterial Thrombosis - Pipeline Insight, 2024
... picture of the Arterial Thrombosis pipeline landscape is provided, which includes the disease overview and Arterial Thrombosis treatment guidelines. The assessment part of the report embraces in-depth Arterial Thrombosis commercial assessment and clinical assessment of ... Read More
-
Acquired Thrombotic Thrombocytopenic Purpura - Pipeline Insight, 2024
... the Acquired Thrombotic Thrombocytopenic Purpura market. A detailed picture of the Acquired Thrombotic Thrombocytopenic Purpura pipeline landscape is provided, which includes the disease overview and Acquired Thrombotic Thrombocytopenic Purpura treatment guidelines. The assessment part of ... Read More
-
ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitor - Pipeline Insight, 2024
... 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitor development. The report ... Read More
-
Chemotherapy Induced Neutropenia - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Chemotherapy Induced Peripheral Neuropathy (CIPN) - Pipeline Insight, 2024
... landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline ... Read More
-
Chemotherapy Induced Febrile Neutropenia - Pipeline Insight, 2024
... drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography ... Read More
-
Cholestatic Pruritus- Pipeline Insight, 2024
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Cholestatic ... Read More
-
Choroideremia - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Choroideremia Understanding ... Read More
-
Chronic Hepatitis C Virus Infection - Pipeline Insight, 2024
... Infection pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the ... Read More
-
Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2024
... Delta Virus (HDV) Infection pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It ... Read More
-
Chronic Inflammatory Demyelinating Polyneuropathy- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Adrenocortical Carcinoma - Market Insight, Epidemiology And Market Forecast - 2034
... USD 12 million in 2023 and is expected to experience consistent growth during the forecast period (2024–2034). Analysts at DelveInsight project that approximately 54% of the Total Diagnosed Prevalent Cases of Molybdenum Cofactor Deficiency Type ... Read More
-
Myasthenia Gravis - Market Insight, Epidemiology And Market Forecast - 2034
... years, immunotherapy has undergone a new phase of development which is linked to the development of CAR-T cell therapy. It is anticipated that CAR-T cells will bring out the next big leap forward in leukemia ... Read More
-
Myelofibrosis (MF) - Market Insight, Epidemiology And Market Forecast - 2034
... the 7MM is expected to increase, driven by the launch of emerging therapies. DelveInsight’s analyst projects that among the total diagnosed prevalent cases of myasthenia gravis in 7MM approximately 45% of cases were from the ... Read More
-
Sjogren's Syndrome - Market Insight, Epidemiology And Market Forecast - 2034
... growing adult population, which is more prone to idiopathic pulmonary arterial hypertension, is adding to the increased cases of pulmonary arterial hypertension. The pulmonary arterial hypertension market is projected to witness consistent growth throughout the ... Read More
-
Alpha Receptor Agonist - Pipeline Insight, 2024
... The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ... Read More
-
Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2024
... and growth prospects across Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline ... Read More
-
Alpha-1 Antagonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Alpha-1 Protease Inhibitor Deficiency - Pipeline Insight, 2024
... the Alpha-1 Protease Inhibitor Deficiency market. A detailed picture of the Alpha-1 Protease Inhibitor Deficiency pipeline landscape is provided, which includes the disease overview and Alpha-1 Protease Inhibitor Deficiency treatment guidelines. The assessment part of ... Read More
-
Alpha-Amylase Inhibitor - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Androgen Agonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Angiotensin Modulators - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Angiotensin Receptor Agonist - Pipeline Insight, 2024
... The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ... Read More
-
Antiapoptotic Protein Targeted Degradation - Pipeline Insight, 2024
... the Antiapoptotic Protein Targeted Degradation market. A detailed picture of the Antiapoptotic Protein Targeted Degradation pipeline landscape is provided, which includes the disease overview and Antiapoptotic Protein Targeted Degradation treatment guidelines. The assessment part of ... Read More
-
Antimicrobial Resistance (AMR) - Pipeline Insight, 2024
... (AMR) market. A detailed picture of the Antimicrobial Resistance (AMR) pipeline landscape is provided, which includes the disease overview and Antimicrobial Resistance (AMR) treatment guidelines. The assessment part of the report embraces in-depth Antimicrobial Resistance ... Read More
Research Assistance
